Immunome (IMNM) Other Non-Current Assets (2019 - 2026)
Immunome (IMNM) posted Other Non-Current Assets of $200000.0 for Q1 2026, down 95.64% on a QoQ basis from $4.6 million in Q4 2025, and up 100.0% year-over-year from $100000.0 in Q1 2025.
Immunome (IMNM) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Immunome's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- Quarterly Other Non-Current Assets rose 100.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (up 100.0% YoY) and the FY2025 annual result came in at $4.6 million, up 3.99% from the prior year.
- Other Non-Current Assets was $200000.0 for Q1 2026 at Immunome, down from $4.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $4.6 million in Q4 2025 and bottomed at $100000.0 in Q1 2022.
- A 5-year average of $891941.2 and a median of $100000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets changed 0.0% — and 2025, when it surged 4455.0%.
- Immunome's Other Non-Current Assets stood at $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then soared by 4311.0% to $4.4 million in 2024, then advanced by 3.99% to $4.6 million in 2025, then plunged by 95.64% to $200000.0 in 2026.
- Business Quant data shows IMNM's Other Non-Current Assets at $200000.0 in Q1 2026, $4.6 million in Q4 2025, and $4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 4.59 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 210,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 4.41 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |